GLIS2 could also regulate the interaction between β-catenin and T-cell factor/Lymphoid enhancer factor (TCF/LEF) to affect the activation of cyclin D1, which may have association with poor tumor differentiation and prognosis in gastric cancer [37]. This evidence concerns the gene CCND1 and gastric cancer.